All Emerging Market articles – Page 37
-
Asset Manager NewsPharmaceutical companies in a golden age for drug discovery
As new technologies such as genomics spur development of innovative drugs, European pharmaceuticals companies stand out as high-quality, defensive growth stocks
-
Asset Manager NewsEurope’s manufacturers are in good shape for a downturn
After reorganising themselves over the past 10 years, many European manufacturers have more flexible business models with higher returns
-
Asset Manager NewsCovid-19: a pandemic with no precedent in a modern economy
The good-news stories and optimism of three months ago have been consigned to the bin, as the virus, lockdowns and economic bailouts take centre stage.
-
White papersCorporate Responsibility | A Moment of Truth
Pushed to its very limits, mankind reveals its true nature. As the health, economic and market crisis unfolds, and at a time when maximizing profits and shareholder returns is no longer the priority, the sincerity of corporate responsibility is being put to test.
-
White papersThe trade-off between staying safe and getting back to work
An economy in lockdown has significant effects for investors in real assets. In this data illustration, our real assets research team consider the benefit of businesses returning to their usual locations against the risks of doing so.
-
White papersGlobal Supply & Demand Curves Shift to the Left
U.S. inflation came in soft for April amid low oil prices and weak global demand. The employment report saw leisure and hospitality with the highest job losses, and Saudi Arabia announced plans to cut oil production again, easing concerns over storage capacity limits worldwide.
-
White papersCOVID-19 Science and Economics
In the second installment of our COVID-19 series, we discusses the scientific and economic implications of the path to recovery with research analyst Camilla Oxhamre Cruse, who has a Ph.D. in medicine and M.Sc. in biochemistry, and global strategist Olga Bitel.
-
White papersWhat We Can Learn from China’s Rapid Normalization
China is further along the coronavirus curve than much of the rest of the world and is on a fast path toward normal. We think its experience bears close watching—not only because China is a major contributor to global economic activity, but also because there will likely be important takeaways for the rest of the world as other countries plan their own reopenings.
-
White papersEquity Investing as We Approach a “New Normal”
Richard Nackenson, Neuberger Berman Equity Senior Portfolio Manager, discusses how investor psychology has changed over the past month and where he is finding investment opportunities as we approach a “new normal.”
-
White papersCoronavirus – weekly update – 13 May 2020
Worldwide COVID-19 cases crossed the 4.3 million mark and the death toll is closing in on 300,000 as of 13 May. The focus is now increasingly shifting to monitoring new cases and fatalities in a second wave that might follow hot on the heels of exit from lockdown.
-
White papersMake the most of the Uncleared Margin Rules extension
On April 3, BCBS-IOSCO announced a one year extension to the final implementation phases of the uncleared margin rules (UMR), citing the ongoing market disruption across the globe resulting from COVID-19. This prompt action still requires approval by local regulators so firms may have to wait for final confirmation of the updated timeline.
-
White papersDid Globalization Kill Contagion?
Does financial globalization lead to contagion? We scrutinize linkages between international stock markets in a long historical perspective (1880-2014). Our results highlight that without globalization, contagion cannot exist. However, if cross-market correlations are very high, globalization kills contagion.
-
White papersHolistic Liquidity Measures During Covid-19: Supply, Demand, and Market Conditions
In late February and early March 2020, global markets experienced an unprecedented health crisis which increased both economic uncertainty and market volatility.
-
White papersMarket weekly – Seize the opportunities with active equity strategies
After the recent strong rally in developed equity markets, senior investment strategist Daniel Morris and Guy Davies, chief investment officer active equity strategies, discuss the outlook and where we see opportunities.
-
White papersThe New Purpose of a Corporation; or, What We’ve Known All Along
Without a doubt, the coronavirus is shaking the financial industry like never before. This is not the first time the world has faced a pandemic of this scale, nor is the first time that policy makers, business leaders and pundits have asked: “Is it different this time around? Are we at a turning point?”
-
White papersThe Day After #2 - Learn The Rules Like A Pro, So You Can Break Them Like An Artist
The vanishing – and probably for long – of most of the established economic rules is a crucial consequence of the crisis. Liberal democracies were living under these rules since the advent of the “Washington Consensus” and the ideological revolution of the 1980s.
-
White papers(Weekly Pandemic) Market Commentary - Exit strategy goes live
Now is a key moment in the Covid-19 crisis, as the lockdowns end. Countries that have opened up early have not seen any significant relapse. But the number of new cases globally has picked up, and selected US States are easing up restrictions too early. V-shaped recovery? Non-sense. Vs ...
-
White papersEmerging Markets After The Coronavirus
The investment case appears battered, but even lower returns may look good when the world gets back to normal.
-
White papersThe New ‘Fusion’
As the physical and digital worlds merge, companies, investors and society will need to adapt.
-
White papersCoronavirus – weekly update – 06 May 2020
As of 6 May, the global COVID-19 case-load has crossed the 3.7 million mark and the number of fatalities exceeds a quarter of a million people. Notwithstanding the usual caution around data comparisons across countries or through time, we highlight the following key features:
